Longvida® and WokVel® synergy for joint support
- 30 November 2021
- Written by LEHVOSS Nutrition
Published clinical studies on both Longvida® and WokVel® offer a good amount of data to demonstrate the potential benefits from a dual mechanism approach to joint comfort and functionality through both 5-LOX and COX-2 pathways. The most relevant results supporting this approach are shown in the new WokVel® & Longvida® Infographic available in our electronic folder and LEHVOSS Nutrition website.
Known for its 5-lipoxygenase (5-LOX) inhibition activity, Boswellia serrata has been used traditionally as a joint solution supporting improved mobility, comfort, joint integrity, and healthy joint aging. Curcuma longa has a well-known and established cyclooxygenase-2 (COX-2) inhibition activity for favourable benefits promoting healthy joints, supporting improved antioxidant capacity, joint comfort, functionality, and healthy joint aging.
Adequate management of both the 5-LOX and COX-2 pathways offers a dual mechanistic approach joint comfort and functionality with clinically supported evidence for fast-acting, long-lasting benefits.
For more information, contact us.
From the same makers of 
As interest grows in GLP‑1 focused products that help manage appetite, more brands are searching... 
Adding Omega‑3 to tablets has never been easier, thanks to 
As winter fades, many people may feel a natural dip in energy. With its full fatty acid profile,... 
